Ronald Muhlenkamp - Muhlenkamp & Co 13F Activity & Position Changes (Q4 2016)

As of Dec 31, 2016, the Muhlenkamp & Co portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 06, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q4 2016, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q4 2016
AAPL
Apple Inc.
Sell
-1,099
Q4 2016
AB
AllianceBernstein Holding L.P.
Buy
+500
Q4 2016
ALGT
Allegiant Travel Company
Buy
+132
Q4 2016
AXL
American Axle & Manufacturing H
Buy
+1,600
Q4 2016
BFH
Bread Financial Holdings, Inc.
Sell
-1,026
Q4 2016
BIIB
Biogen Inc.
Sell
-199
Q4 2016
BMY
Bristol-Myers Squibb Company
Sell
-1,355
Q4 2016
CCJ
Cameco Corporation
Buy - Position Entry
+551,392
Q4 2016
CE
Celanese Corporation
Sell
-1,100
Q4 2016
CYH
Community Health Systems, Inc.
Sell
-2,965
Q4 2016
DAL
Delta Air Lines, Inc.
Sell
-1,035
Q4 2016
DSL
DoubleLine Income Solutions Fun
Sell - Position Exit
-33,720
Q4 2016
FHI
Federated Hermes, Inc.
Buy - Position Entry
+299,866
Q4 2016
G9456A100
Golar LNG
Buy
+300
Q4 2016
GILD
Gilead Sciences, Inc.
Sell
-1,500
Q4 2016
GLD
SPDR Gold Trust
Sell
-1,270
Q4 2016
GME
GameStop Corporation
Buy - Position Entry
+263,124
Q4 2016
HBI
Hanesbrands Inc.
Buy
+69,171
Q4 2016
LYB
LyondellBasell
Sell
-400
Q4 2016
MCK
McKesson Corporation
Buy
+26,014
Q4 2016
MGNX
MacroGenics, Inc.
Buy
+641
Q4 2016
MSFT
Microsoft Corporation
Sell
-1,725
Q4 2016
OLED
Universal Display Corporation
Sell
-100
Q4 2016
ON
ON Semiconductor Corporation
Sell
-9,260
Q4 2016
PFE
Pfizer, Inc.
Sell
-2,050
Q4 2016
RUSHB
Rush Enterprises, Inc.
Sell
-115
Q4 2016
SAVE
Spirit Airlines, Inc.
Sell
-8,695
Q4 2016
SLB
Schlumberger N.V.
Buy
+13,786
Q4 2016
TCEHY
Tencent Holding Ltd.
Sell
-2,422
Q4 2016
TEVA
Teva Pharmaceutical Industries
Buy
+64,119
Page 1 of 2